Replies to post #12438 on Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

I'm very aware of Blue and happy for my friends that are long this stock with the way it's surged higher lately. As far as Blue and SCD are concerned, they have only dosed one patient and the company states that they don't have enough data to show significant efficacy. MAST is years ahead of Blue in the area of SCD and I'm excited for similar monster break outs to the upside for our company in 2015!!!